Selection of individuals who may benefit from pancreatic cancer surveillance
2024

Pancreatic Cancer Surveillance: Who Should Be Monitored?

Sample size: 263 Editorial Evidence: moderate

Author Information

Author(s): Bruno Marco J.

Primary Institution: Erasmus MC – University Medical Center Rotterdam

Hypothesis

Is pancreatic cancer surveillance effective for individuals without gene variants?

Conclusion

Current surveillance strategies for individuals at risk without gene variants are ineffective and may lead to unnecessary procedures.

Supporting Evidence

  • The study found a 13.5% diagnostic yield for variant carriers compared to 0.8% for variant-negative individuals.
  • 80% of surgeries performed on variant-negative individuals were unnecessary.
  • The current age for starting surveillance may be too young for effective detection.

Takeaway

This study looks at whether people without certain gene variants should be checked for pancreatic cancer. It finds that the checks might not help them and could even cause more problems.

Methodology

The study analyzed 20 years of surveillance data from familial pancreatic cancer families, comparing outcomes between variant carriers and variant-negative individuals.

Potential Biases

There is a risk of ascertainment bias affecting the identification of individuals at high risk.

Limitations

The study does not provide new data and relies on existing reports, which may limit the generalizability of its conclusions.

Participant Demographics

Participants included individuals from familial pancreatic cancer families, with a focus on variant carriers and variant-negative individuals.

Statistical Information

P-Value

<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1002/ueg2.12660

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication